×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
戻る Agenda
Opening Plenary Session
Session Chair(s)
E. Stewart Geary, MD
MD, Global Safety Officer
Eisai Co., Ltd., Japan
Pharmacovigilance is among the most critical aspects of a medical product, that ensures that the products are risk-managed in their use. The changing landscape of medicine and evolving technology in pharmaceuticals such as nanotechnology, make the PV requirements more specific. These challenges pronounce more with special events like special audits, mergers and acquisitions.
Speaker(s)
Safety Risk & Pharmacovigilance of Nanoparticles Used in Drugs
Alok Dhawan
Centre of Biomedical Research, India
Director
Advanced Technology As The Strategic Enabler for Pharma R&D
Aman Wasan
ArisGlobal, United States
CEO